BRIEF-TG therapeutics announces completion of enrollment and B-cell depletion data from part 1 of ongoing phase 2 multiple sclerosis study

* TG therapeutics announces completion of enrollment and

B-cell depletion data from part 1 of ongoing phase 2 multiple

sclerosis study

Read more